SELLAS Life Sciences (SLS) Gross Profit (2012 - 2022)

SELLAS Life Sciences (SLS) reported Gross Profit of $900000.0 for Q1 2022, down 83.93% year-over-year from $5.6 million in Q1 2021, and down 50.0% on a QoQ basis from $1.8 million in Q2 2021.

SELLAS Life Sciences (SLS) has 7 years of Gross Profit data on file, last reported at $900000.0 in Q1 2022.

  • Quarterly Gross Profit fell 83.93% year-over-year to $900000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $900000.0 (down 87.84% YoY) and the FY2022 annual result came in at $900000.0, down 87.84% from the prior year.
  • Gross Profit eased to $900000.0 in Q1 2022 per SLS's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Gross Profit topped out at $5.6 million in Q1 2021 and bottomed at $900000.0 in Q1 2022.
  • The 3-year median for Gross Profit is $1.8 million (2020), against an average of $2.6 million.
  • Peak annual rise in Gross Profit reached 83.93% in 2022, while the deepest fall reached 83.93% in 2022.
  • Tracing SLS's Gross Profit over 3 years: stood at $1.9 million in 2020, then declined by 5.26% to $1.8 million in 2021, then tumbled by 50.0% to $900000.0 in 2022.
  • Per Business Quant, the three latest SLS Gross Profit figures stand at $900000.0 (Q1 2022), $1.8 million (Q2 2021), and $5.6 million (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 900,000.00
Mar 31, 2022 900,000.00
Jun 30, 2021 1.80 Mn
Jun 30, 2021 1.80 Mn
Mar 31, 2021 5.60 Mn
Mar 31, 2021 5.60 Mn
Dec 31, 2020 1.90 Mn
Dec 31, 2020 1.90 Mn
Jun 30, 2015 2.91 Mn
Jun 30, 2015 2.91 Mn
Mar 31, 2015 2.36 Mn
Mar 31, 2015 2.36 Mn
Dec 31, 2014 2.72 Mn
Dec 31, 2014 2.72 Mn
Sep 30, 2014 1.37 Mn
Sep 30, 2014 1.37 Mn
Jun 30, 2014 1.98 Mn
Jun 30, 2014 1.98 Mn
Mar 31, 2014 1.84 Mn
Mar 31, 2014 1.84 Mn
Dec 31, 2013 2.93 Mn
Dec 31, 2013 2.93 Mn
Sep 30, 2013 869,000.00
Sep 30, 2013 869,000.00
Jun 30, 2013 2.33 Mn
Jun 30, 2013 2.33 Mn
Mar 31, 2013 2.17 Mn
Mar 31, 2013 2.17 Mn
Dec 31, 2012 -1.17 Mn
Dec 31, 2012 -1.17 Mn